BioNumerik Pharmaceuticals Garners $9,491,000 New Financing Round

  • Feed Type
  • Date
    12/31/2012
  • Company Name
    BioNumerik Pharmaceuticals
  • Mailing Address
    8122 Datapoint Drive San Antonio, TX 78229
  • Company Description
    Our vision is to discover and develop innovative new cancer treatments by the integration of medicine, pharmaceutical sciences, physics-based molecular simulation and high-performance information technology.
  • Website
    http://www.bionumerik.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $9,491,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy